Heron Therapeutics Announces Inclusion of APONVIE(R) (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV) GlobeNewswire December 04, 2025 APONVIE, an aprepitant product, highlighted as the only FDA-approved IV formulation Neurokinin-1 (“NK-1”) antagonist indicated for the prevention of PONV in adults, with a long half-life […]

The National Police Association (NPA) today announced the filing of an amicus curiae brief with the U.S. Supreme Court in support of Los Angeles Police Department Officer Toni McBride, framing her case as a pivotal stand for America's embattled law enforcement. The brief, submitted in City of Los Angeles v. Estate of Daniel Hernandez (No.

VSee Health AI telehealth technology leader highlights client success and growing market momentum in virtual care SAN JOSE, CALIFORNIA / ACCESS Newswire / December 4, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a leading provider of AI telehealth technology solutions, announces an upcoming webinar today with Novant Health Urgent Care, the largest urgent care provider in

— Phase 3 CDKL5 deficiency disorder (CDD) results: UCB shares 21 scientific abstracts, including the presentation of positive primary efficacy and safety results from a phase 3 study of FINTEPLA®(fenfluramine)1 inCDD, marking the third developmental and epileptic encephalopathy (DEE) to see positive results following Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS).2 — Open-label extension study

Trading resumes in: Company: FireFly Metals Ltd. TSX Symbol: FFM All Issues: Yes Resumption (ET): 8:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which

Brevo, a European leader in customer engagement software, has closed its latest €500 million financing round, officially becoming a unicorn. General Atlantic, a leading global investor, and Oakley Capital, a leading, pan-European mid-market investor, are joining the Company's shareholders. Bpifrance and Bridgepoint, one of the world's leading mid-market investors, remain minority investors, with the latter

Pilot Program Addresses Rising Costs, Vendor Churn, and the Operational Burden of Disconnected School Safety Systems Navigate360, the nation's leading provider of holistic school safety and well-being solutions, today announced the Navigate360 Platform Readiness Pilot Program, a national early-adoption initiative designed to help districts transition from fragmented, short-lived safety tools into a unified, data-driven safety

Report from SAS and United Nations shares best practices in climate risk management As financial institutions worldwide grapple with how to turn climate-related risks into credible stress testing scenarios, new guidance on climate stress testing for banks offers a timely roadmap. Stress testing helps banks identify vulnerabilities, meet evolving regulations and build resilience into portfolios.

Strategic Structural Update Positions ProPharma As Market Leader ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced that it has welcomed Dan Ryan as its new President of Clinical Research Solutions (CRS). In this role, Dan will be

(NYSE:FCX), LOS ANGELES, Dec. 04, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Freeport-McMoRan Inc. (“Freeport” or “the Company”) (NYSE: FCX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders